Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to evaluate the radiation dose to patient at two positions (prone and left lateral) and to medical staff during Endoscopic retrograde cholangiopancreatography (ERCP) procedure using dose area product (DAP) meter and thermoluminescent dosimeter (TLD). Data were recorded on 20 patients at prone position and 20 patients at left lateral position.


Clinical Trial Description

The radiographic-fluoroscopic system manufactured by Siemens Model POLYSTAR was used for ERCP procedure at King Chulalongkorn Memorial Hospital. Dose Area Product (DAP) manufactured by PTW Model DIAMENTOR E, a transmission ionization chamber was attached to X-ray collimator to record the dose-area (cGy.cm2) in order to determine the entrance surface air kerma (ESAK, mGy) of the patients at two positions (prone and left lateral) while the Kodak Portal Pack for localization imaging was placed on the patient's couch to determine the exposed area (cm2) on the surface of the patient. TLD was attached at five positions, left eye, thyroid, left forearm, lower abdomen and left leg of the medical staff during ERCP procedure. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT01599351
Study type Interventional
Source Chulalongkorn University
Contact
Status Completed
Phase Phase 4
Start date July 2009
Completion date January 2010

See also
  Status Clinical Trial Phase
Completed NCT01794325 - Transradial and Transfemoral Coronary Angiography by EXPERienced operaTors N/A
Completed NCT01677481 - Randomized Evaluation of Vascular Entry Site and Radiation Exposure: REVERE Trial N/A
Completed NCT01334931 - Use of Large Field of View During Image Acquisition for Coronary Angiography Phase 3